Anuh Pharma Limited (NSE:ANUHPHR)
93.11
+1.90 (2.08%)
Sep 11, 2026, 11:20 AM IST
Anuh Pharma Revenue
Anuh Pharma had revenue of 1.94B INR in the quarter ending June 30, 2026, with 3.93% growth. This brings the company's revenue in the last twelve months to 7.79B, up 9.70% year-over-year. In the fiscal year ending March 31, 2026, Anuh Pharma had annual revenue of 7.72B with 16.65% growth.
Revenue (ttm)
7.79B
Revenue Growth
+9.70%
P/S Ratio
1.18
Revenue / Employee
24.12M
Employees
323
Market Cap
9.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.72B | 1.10B | 16.65% |
| Mar 31, 2025 | 6.62B | 145.11M | 2.24% |
| Mar 31, 2024 | 6.47B | 1.20B | 22.66% |
| Mar 31, 2023 | 5.27B | 408.40M | 8.39% |
| Mar 31, 2022 | 4.87B | 546.86M | 12.66% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Indoco Remedies | 18.73B |
| Solara Active Pharma Sciences | 14.31B |
| Windlas Biotech | 9.42B |
| Sigachi Industries | 4.76B |
| Beta Drugs | 4.10B |
| Valiant Laboratories | 3.06B |
| Jagsonpal Pharmaceuticals | 2.94B |
| Amanta Healthcare | 2.91B |
Anuh Pharma News
- 4 weeks ago - Anuh Pharma Quarterly report: Q1 2027 - Filings
- 4 weeks ago - Anuh Pharma Slides: Q1 2027 - Filings
- 3 months ago - Anuh Pharma Slides: Investor presentation - Filings
- 3 months ago - Anuh Pharma Quarterly report: Q4 2026 - Filings
- 3 months ago - Anuh Pharma Annual report: Q4 2026 - Filings
- 7 months ago - Anuh Pharma Quarterly report: Q3 2026 - Filings
- 9 months ago - Anuh Pharma Secures EDQM Certificate of Suitability for Sulfadimethoxine - Business Upturn
- 10 months ago - Anuh Pharma Quarterly report: Q2 2026 - Filings